Antimicrobial Susceptibility Trends among Staphylococcus aureus Isolates from U.S. Hospitals: Results from 7 Years of the Ceftaroline (AWARE) Surveillance Program, 2010 to 2016.

about

Pharmacotherapeutic options for treating Staphylococcus aureus bacteremia.

P2860

Q47634145-9961AF82-7824-4DAD-8AAF-38E7540E5A26

P2860

Antimicrobial Susceptibility Trends among Staphylococcus aureus Isolates from U.S. Hospitals: Results from 7 Years of the Ceftaroline (AWARE) Surveillance Program, 2010 to 2016.

Item

http://www.wikidata.org/entity/Q40166186

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Antimicrobial Susceptibility T ...... illance Program, 2010 to 2016.

@en

type

Item

label

Antimicrobial Susceptibility T ...... illance Program, 2010 to 2016.

@en

prefLabel

Antimicrobial Susceptibility T ...... illance Program, 2010 to 2016.

@en

P1476

Antimicrobial Susceptibility T ...... illance Program, 2010 to 2016.

@en

P2093

Jennifer M Streit

http://www.w3.org/2001/XMLSchema#string

Rodrigo E Mendes

http://www.w3.org/2001/XMLSchema#string

P2860

Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic

Life After USA300: The Rise and Fall of a Superbug.

Antimicrobial-Resistant Pathogens Associated With Healthcare-Associated Infections: Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2011-2014.

Waves of resistance: Staphylococcus aureus in the antibiotic era.

Community-associated MRSA: what makes them special?

Staphylococcus aureus bacteremia at 5 US academic medical centers, 2008-2011: significant geographic variation in community-onset infections

Emergence of multidrug-resistant, community-associated, methicillin-resistant Staphylococcus aureus clone USA300 in men who have sex with men.

Antimicrobial resistance: Not community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA)! A clinician's guide to community MRSA - its evolving antimicrobial resistance and implications for therapy.

Ceftaroline fosamil: a review of its use in the treatment of complicated skin and soft tissue infections and community-acquired pneumonia.

Antimicrobial Activity of Ceftaroline Tested against Staphylococcus aureus from Surgical Skin and Skin Structure Infections in US Medical Centers.

P31

scholarly article

P356

10.1128/AAC.01043-17

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Helio S Sader

Robert K Flamm

P577

2017-06-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28630196

http://www.w3.org/2001/XMLSchema#string

P932

5571371

http://www.w3.org/2001/XMLSchema#string

Antimicrobial Susceptibility Trends among Staphylococcus aureus Isolates from U.S. Hospitals: Results from 7 Years of the Ceftaroline (AWARE) Surveillance Program, 2010 to 2016.

about

P2860

P2860

Antimicrobial Susceptibility Trends among Staphylococcus aureus Isolates from U.S. Hospitals: Results from 7 Years of the Ceftaroline (AWARE) Surveillance Program, 2010 to 2016.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P31

P356

P407

P433

P478

P50

P577

P698

P932